Intangible assets, net

9 Months Ended

Sep. 30, 2017

Intangible assets, net [Abstract]

Intangible assets, net

7. Intangible assets, net

At September 30, 2017 and December 31, 2016, intangible assets, primarily consisting of acquired patents, and accumulated amortization were as follows (in thousands):

	September 30, 2017 (unaudited)(1)			December 31, 2016
Intangible assets	$	23,294		$	25,703
Accumulated amortization		(15,812	)		(15,497	)
Intangible assets, net	$	7,482		$	10,206

⁽¹⁾ Reflects the effect of the OncoCyte Deconsolidation.

BioTime recognized $1.8 million and $2.9 million in amortization expense of intangible assets, included in research and development expenses, during the nine months ended September 30, 2017 and 2016, respectively.